Insider · CIK 0001586657

Leaman John Harold

Reports to the SEC for 4 companies · NEWTOWN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001586657

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-09	TRAWTraws Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14.2K sh	—	—	14,150
2026-03-08	TRAWTraws Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+33.4K sh	—	—	33,435
2025-12-12	TRAWTraws Pharma, Inc.A Award	Director	AAward	+4,058 sh	—	—	4,058
2025-12-12	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Director	AAward	+16.2K sh	—	—	16,234
2025-11-21	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Director	AAward	+12.8K sh	—	—	12,770
2025-10-01	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Director	AAward	+15.6K sh	—	—	15,609
2023-02-14	IPI Legacy Liquidation CoStock Option (right to buy)A Award	Chief Fin. & Business Officer	AAward	+70K sh	—	—	70,000
2022-12-31	IPI Legacy Liquidation CoM Exercise/Conversion	Chief Fin. & Business Officer	MExercise/Conversion	+10.6K sh	—	—	10,571
2022-12-31	IPI Legacy Liquidation CoF Tax Payment	Chief Fin. & Business Officer	FTax Payment	−3,627 sh	$3.75	−$13.6K	6,944
2022-12-31	IPI Legacy Liquidation CoRestricted Stock Units (RSUs)M Exercise/Conversion	Chief Fin. & Business Officer	MExercise/Conversion	−10.6K sh	—	—	0
2022-01-26	IPI Legacy Liquidation CoStock Option (right to buy)A Award	Chief Fin. & Business Officer	AAward	+100K sh	—	—	100,000
2021-10-19	IPI Legacy Liquidation CoRestricted Stock Units (RSUs)A Award	Chief Fin. & Business Officer	AAward	+10.6K sh	—	—	10,571
2021-07-20	IPI Legacy Liquidation CoStock Option (right to buy)A Award	Chief Fin. & Business Officer	AAward	+50K sh	—	—	50,000
2018-06-15	RNACCartesian Therapeutics, Inc. · Stock Option (right to buy)A Award	CFO, Treas. & Hd Corp Strategy	AAward	+50K sh	—	—	50,000
2017-11-17	RNACCartesian Therapeutics, Inc. · Stock Option (right to buy)A Award	CFO, Treas. & Hd Corp Strategy	AAward	+220K sh	—	—	220,000
2015-02-18	Aevi Genomic Medicine, LLCOption Award (right to buy)A Award	Chief Financial Officer	AAward	+140K sh	—	—	140,000
2013-09-13	Aevi Genomic Medicine, LLCOption Award (right to buy)A Award	Chief Financial Officer	AAward	+800K sh	—	—	800,000

Recent filings

Accepted (ET)
Jul 144
Leaman John Harold0001586657-26-000003
SEC(opens sec.gov)
Mar 104
Leaman John Harold0001586657-26-000002
SEC(opens sec.gov)
Dec 164
Leaman John Harold0001586657-25-000008
SEC(opens sec.gov)
Nov 254
Leaman John Harold0001586657-25-000007
SEC(opens sec.gov)
Oct 144
Leaman John Harold0001586657-25-000005
SEC(opens sec.gov)
Feb 164
Leaman John Harold0001209191-23-010245
SEC(opens sec.gov)
Jan 44
Leaman John Harold0001209191-23-001365
SEC(opens sec.gov)
Jan 284
Leaman John Harold0001209191-22-005450
SEC(opens sec.gov)
Oct 214
Leaman John Harold0001209191-21-061281
SEC(opens sec.gov)
Jul 264
Leaman John Harold0001209191-21-048219
SEC(opens sec.gov)
Jun 194
Leaman John Harold0001638599-18-000677
SEC(opens sec.gov)
Nov 204
Leaman John Harold0001638599-17-001156
SEC(opens sec.gov)
Feb 204
MEDGENICS, INC.0001144204-15-011082
SEC(opens sec.gov)
Sep 174
MEDGENICS, INC.0001144204-13-051293
SEC(opens sec.gov)

Companies

Address

C/O TRAWS PHARMA, INC. 12 PENNS TRAIL

NEWTOWN, PA, 18940